Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Abiraterone acetate in Male Genital Neoplasms: CTRI/2026/06/112300 Clinical Landscape Report 2026
28 September 2026
CTRI/2026/06/112300 clinical landscape for Male Genital Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludarabine Phosphate in Metastatic castration-resistant prostate cancer: NCT07641049 Clinical Landscape Report 2026
28 September 2026
NCT07641049 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
Allopurinol in Musculoskeletal Diseases: ACTRN12626000741381 Clinical Landscape Report 2026
28 September 2026
ACTRN12626000741381 clinical landscape for Musculoskeletal Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Coated Aldehyde Oxystarch in Kidney Failure, Chronic: NCT07653711 Clinical Landscape Report 2026
28 September 2026
NCT07653711 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
DEC003M in Advanced Prostate Carcinoma: NCT07657806 Clinical Landscape Report 2026
28 September 2026
NCT07657806 clinical landscape for Advanced Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pralsetinib in Metastatic Solid Tumor: NCT07704658 Clinical Landscape Report 2026
28 September 2026
NCT07704658 clinical landscape for Metastatic Solid Tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Alvespimycin Hydrochloride in Kidney Failure, Chronic: NCT07663279 Clinical Landscape Report 2026
28 September 2026
NCT07663279 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sacituzumab tirumotecan in Metastatic Malignant Neoplasm to the Leptomeninges: NCT07702305 Clinical Landscape Report 2026
28 September 2026
NCT07702305 clinical landscape for Metastatic Malignant Neoplasm to the Leptomeninges: endpoints, sponsor, phase, geography, readouts, asset context and deve…
9 min read
Finerenone in Diabetes Mellitus, Type 2: NCT07667517 Clinical Landscape Report 2026
28 September 2026
NCT07667517 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Serplulimab in Locally Advanced Gastroesophageal Junction Adenocarcinoma: NCT07674342 Clinical Landscape Report 2026
28 September 2026
NCT07674342 clinical landscape for Locally Advanced Gastroesophageal Junction Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context a…
9 min read
AD-236A (Addpharma, Inc.) in Diabetes Mellitus, Type 2: NCT07730567 Clinical Landscape Report 2026
28 September 2026
NCT07730567 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tirzepatide in Type 2 diabetes mellitus in obese: NCT07728318 Clinical Landscape Report 2026
28 September 2026
NCT07728318 clinical landscape for Type 2 diabetes mellitus in obese: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…